Respiratory

Back to articles

Smoking cessation: More on nicotinic receptor agonists

KEY POINT

Two novel alternatives for smoking cessation— the recently approved nicotinic activator varenicline (Chantix—Pfizer) and a related drug, cytisine (Tabex—Sopharma JSCo), used commonly in Eastern Europe for the past 40 years—were subjects of articles published recently in the Archives of Internal Medicine.